PHW:CA:TSX-Purpose International Tactical Hedged Equity (CAD)

COMMON STOCK | |

Last Closing

CAD 19.19

Change

-0.01 (-0.05)%

Market Cap

CAD 4.21M

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-09 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TD-PFD:CA Toronto Dominion Bank Pref D

+0.02 (+0.08%)

CAD 175.27B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

-0.02 (-0.08%)

CAD 164.61B
ENB-PFA:CA Enbridge Inc Pref 9

-0.05 (-0.24%)

CAD 123.93B
ENB-PFV:CA Enbridge Inc Pref 5

N/A

CAD 121.40B
ENB-PFC:CA Enbridge Inc Pref 11

-0.01 (-0.05%)

CAD 117.12B
ENB-PFG:CA Enbridge Inc Pref 15

+0.06 (+0.31%)

CAD 112.40B
ENB-PFU:CA Enbridge Inc Pref L

-0.10 (-0.45%)

CAD 88.56B
PPL-PFA:CA Pembina Pipeline Corp Pref Ser..

+0.02 (+0.08%)

CAD 9.66B
EIT-UN:CA Canoe EIT Income Fund

+0.09 (+0.58%)

CAD 2.69B
EVT:CA Economic Investment Trust Ltd

N/A

CAD 0.92B

ETFs Containing PHW:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.95% N/A N/A 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.95% N/A N/A 59% D-
Trailing 12 Months  
Capital Gain 7.21% N/A N/A 39% F
Dividend Return 1.68% N/A N/A 21% F
Total Return 8.88% N/A N/A 35% F
Trailing 5 Years  
Capital Gain -0.05% N/A N/A 39% F
Dividend Return 9.90% N/A N/A 22% F
Total Return 9.84% N/A N/A 27% F
Average Annual (5 Year Horizon)  
Capital Gain 2.65% N/A N/A 43% F
Dividend Return 3.21% N/A N/A 38% F
Total Return 0.55% N/A N/A 33% F
Risk Return Profile  
Volatility (Standard Deviation) 7.84% N/A N/A 82% B
Risk Adjusted Return 40.94% N/A N/A 53% F
Market Capitalization 4.21M N/A N/A 3% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike